Vistin Pharma ASA (DE:VP4) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Saga Pure ASA has increased its stake in Vistin Pharma ASA by acquiring an additional 250,000 shares at a price of NOK 25.13 each, taking its total ownership to 1.47%. Following the transaction, board member Øystein Stray Spetalen and his associated companies hold a combined 5.02% of Vistin Pharma. The purchase took place on the Oslo Stock Exchange on September 13, 2024.
For further insights into DE:VP4 stock, check out TipRanks’ Stock Analysis page.